DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA
LOS COMPUESTOS CON LA FORMULA I SON UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ASOCIADAS A LA DISMINUCION DE LOS RECEPTORES NICOTINICOS EN LOS MAMIFEROS. EN LA QUE X CORRESPONDE A: A) CH 2 NR 1 R 2 B) O C) Y R, R 1 Y R 2 CORRESPONDEN INDEPENDIENTEMENTE A UN HIDROGENO Y UN ALQUILO C SUB,1 C 6 ; R 3...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NAGEL, ARTHUR ADAM |
| description | LOS COMPUESTOS CON LA FORMULA I SON UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ASOCIADAS A LA DISMINUCION DE LOS RECEPTORES NICOTINICOS EN LOS MAMIFEROS. EN LA QUE X CORRESPONDE A: A) CH 2 NR 1 R 2 B) O C) Y R, R 1 Y R 2 CORRESPONDEN INDEPENDIENTEMENTE A UN HIDROGENO Y UN ALQUILO C SUB,1 C 6 ; R 3 SE SELECCIONA ENTRE UN HIDROGENO, UN HALOGENO Y UN ALQUILO C 1 C 6 ; I EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4; M EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4, Y N EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 2; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH2NR R , b) or; c) and R,R and R are independently selected from hydrogen and C1-C6 alkyl; R is selected from hydrogen, halogen and C1-C6 alkyl; l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2175615TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2175615TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2175615TT33</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRbexEPUO4wEsYojWw-6oA5sZSUYLEUKQtRINxPujCR7A5r_mvT9110AVnzFoDYEAL8gSNAIZRyxZELyWCrgnMRqVk7AKYISKPB1NKxD2ajzseOGH1mv8xnM3ubePPi1-nLnljswfVql7Nanv2lt6pndD9TrbFpusMMvzf5wPiLcyYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA</title><source>esp@cenet</source><creator>NAGEL, ARTHUR ADAM</creator><creatorcontrib>NAGEL, ARTHUR ADAM</creatorcontrib><description>LOS COMPUESTOS CON LA FORMULA I SON UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ASOCIADAS A LA DISMINUCION DE LOS RECEPTORES NICOTINICOS EN LOS MAMIFEROS. EN LA QUE X CORRESPONDE A: A) CH 2 NR 1 R 2 B) O C) Y R, R 1 Y R 2 CORRESPONDEN INDEPENDIENTEMENTE A UN HIDROGENO Y UN ALQUILO C SUB,1 C 6 ; R 3 SE SELECCIONA ENTRE UN HIDROGENO, UN HALOGENO Y UN ALQUILO C 1 C 6 ; I EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4; M EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4, Y N EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 2; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH2NR R , b) or; c) and R,R and R are independently selected from hydrogen and C1-C6 alkyl; R is selected from hydrogen, halogen and C1-C6 alkyl; l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof.</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021116&DB=EPODOC&CC=ES&NR=2175615T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021116&DB=EPODOC&CC=ES&NR=2175615T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAGEL, ARTHUR ADAM</creatorcontrib><title>DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA</title><description>LOS COMPUESTOS CON LA FORMULA I SON UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ASOCIADAS A LA DISMINUCION DE LOS RECEPTORES NICOTINICOS EN LOS MAMIFEROS. EN LA QUE X CORRESPONDE A: A) CH 2 NR 1 R 2 B) O C) Y R, R 1 Y R 2 CORRESPONDEN INDEPENDIENTEMENTE A UN HIDROGENO Y UN ALQUILO C SUB,1 C 6 ; R 3 SE SELECCIONA ENTRE UN HIDROGENO, UN HALOGENO Y UN ALQUILO C 1 C 6 ; I EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4; M EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4, Y N EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 2; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH2NR R , b) or; c) and R,R and R are independently selected from hydrogen and C1-C6 alkyl; R is selected from hydrogen, halogen and C1-C6 alkyl; l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRbexEPUO4wEsYojWw-6oA5sZSUYLEUKQtRINxPujCR7A5r_mvT9110AVnzFoDYEAL8gSNAIZRyxZELyWCrgnMRqVk7AKYISKPB1NKxD2ajzseOGH1mv8xnM3ubePPi1-nLnljswfVql7Nanv2lt6pndD9TrbFpusMMvzf5wPiLcyYw</recordid><startdate>20021116</startdate><enddate>20021116</enddate><creator>NAGEL, ARTHUR ADAM</creator><scope>EVB</scope></search><sort><creationdate>20021116</creationdate><title>DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA</title><author>NAGEL, ARTHUR ADAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2175615TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NAGEL, ARTHUR ADAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAGEL, ARTHUR ADAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA</title><date>2002-11-16</date><risdate>2002</risdate><abstract>LOS COMPUESTOS CON LA FORMULA I SON UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ASOCIADAS A LA DISMINUCION DE LOS RECEPTORES NICOTINICOS EN LOS MAMIFEROS. EN LA QUE X CORRESPONDE A: A) CH 2 NR 1 R 2 B) O C) Y R, R 1 Y R 2 CORRESPONDEN INDEPENDIENTEMENTE A UN HIDROGENO Y UN ALQUILO C SUB,1 C 6 ; R 3 SE SELECCIONA ENTRE UN HIDROGENO, UN HALOGENO Y UN ALQUILO C 1 C 6 ; I EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4; M EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 4, Y N EQUIVALE A UN NUMERO ENTERO ENTRE 0 Y 2; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH2NR R , b) or; c) and R,R and R are independently selected from hydrogen and C1-C6 alkyl; R is selected from hydrogen, halogen and C1-C6 alkyl; l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2175615TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DERIVADOS DE AZAINDOL ETILAMINA COMO AGENTES DE UNION AL RECEPTOR NICOTINICO DE ACETILCOLINA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A31%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAGEL,%20ARTHUR%20ADAM&rft.date=2002-11-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2175615TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |